Translate this page into:
Iron status in ESRD patients
Address for correspondence: Prof. Viroj Wiwanitkit, Wiwanitkit House, Bangkhae, Bangkok – 10160, Thailand E-mail: wviroj@yahoo.com
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This article was originally published by Medknow Publications and was migrated to Scientific Scholar after the change of Publisher.
Sir,
I read the recent report on iron status in ESRD patients with a great interest.[1] Jairam et al. concluded that “our ESRD patients showed marked inflammatory activation, which was more pronounced in patients who had received IV iron.”[1] I agree that the study on the ESRD patients is very interesting. I would like to add some more possible clinical explanations to the observation. Recently, Finkelstein et al. studied the correlation between hemoglobin, vitamin C, and peritoneal dialysis.[2] Indeed, the relationship between vitamin C and iron status is confirmed, and vitamin C[3] is also proposed for a possible relationship with hepcidin.[4]
References
- Iron status, inflammation and hepcidin in ESRD patients: The confounding role of intravenous iron therapy. Indian J Nephrol. 2010;20:125-31.
- [Google Scholar]
- Hemoglobin and plasma vitamin c levels in patients on peritoneal dialysis. Perit Dial Int. 2011;31:74-9.
- [Google Scholar]
- Iron content, bioavailability and factors affecting iron status of Indians. Indian J Med Res. 2009;130:634-45.
- [Google Scholar]
